Behandling af ST segment elevations myokardieinfarkt (STEMI) OASIS 6 var en dobbeltblindet, randomiseret undersøgelse til vurdering af sikkerhed og effekt ved subkutan administration af fondaparinux 2, 5 mg én gang daglig versus sædvanlig behandling (placebo (47%) eller UFH (53%)) blandt ca.
Treatment of ST segment elevation myocardial infarction (STEMI) OASIS 6 was a double blind, randomised study assessing the safety and efficacy of fondaparinux 2.5 mg once daily, versus usual care (placebo (47%) or UFH (53%) in approximately 12,000 patients with STEMI.